Louisiana State Employees Retirement System Makes New Investment in Ingevity Corporation $NGVT

Louisiana State Employees Retirement System acquired a new stake in Ingevity Corporation (NYSE:NGVT) during the 1st quarter, Holdings Channel reports. The institutional investor acquired 15,900 shares of the company’s stock, valued at approximately $1,133,000.

Other hedge funds also recently made changes to their positions in the company. Advisory Services Network LLC boosted its stake in shares of Ingevity by 4.4% during the 3rd quarter. Advisory Services Network LLC now owns 6,947 shares of the company’s stock worth $383,000 after acquiring an additional 293 shares during the period. Amundi raised its stake in Ingevity by 4.8% in the 3rd quarter. Amundi now owns 6,626 shares of the company’s stock valued at $364,000 after acquiring an additional 302 shares during the period. Isthmus Partners LLC raised its stake in Ingevity by 0.5% in the 4th quarter. Isthmus Partners LLC now owns 72,245 shares of the company’s stock valued at $4,275,000 after acquiring an additional 375 shares during the period. Geneos Wealth Management Inc. raised its stake in Ingevity by 85.8% in the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after acquiring an additional 387 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in Ingevity by 39.6% during the 4th quarter. GAMMA Investing LLC now owns 1,524 shares of the company’s stock valued at $90,000 after purchasing an additional 432 shares during the last quarter. 91.59% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, SVP Terrance M. Dyer sold 496 shares of the firm’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the transaction, the senior vice president directly owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.88% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on NGVT shares. Wall Street Zen cut shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 29th. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research report on Tuesday, April 21st. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Ingevity presently has an average rating of “Hold” and an average price target of $80.00.

Ingevity Stock Performance

Shares of NYSE NGVT opened at $72.28 on Friday. The company has a debt-to-equity ratio of 27.83, a current ratio of 1.42 and a quick ratio of 0.92. The stock’s fifty day moving average price is $71.23 and its two-hundred day moving average price is $69.10. Ingevity Corporation has a one year low of $39.74 and a one year high of $79.29. The firm has a market cap of $2.51 billion, a price-to-earnings ratio of -20.36 and a beta of 1.16.

Ingevity (NYSE:NGVT) last posted its earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.31. The company had revenue of $258.00 million during the quarter, compared to the consensus estimate of $254.73 million. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The company’s revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.01 earnings per share. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, equities analysts forecast that Ingevity Corporation will post 5.05 EPS for the current year.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.